(Q41507868)

1 October 2017

1 reference

title

The pathophysiology and treatment of postmenopausal osteoporosis. An evidence-based approach to estrogen replacement therapy (English)

1 reference

1 October 2017

Rosen CJ

1

1 reference

PubMed ID

9193885

1 October 2017

Kessenich CR

series ordinal

2

1 reference

1 October 2017

1 June 1997

1 reference

Endocrinology and Metabolism Clinics of North America

1 October 2017

1 reference

1 October 2017

26

1 reference

1 October 2017

295-311

1 reference

1 October 2017

2

1 reference

POSTMENOPAUSAL OSTEOPOROSIS

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Sex differences in bone mineral density in 1653 men and women in the sixth through tenth decades of life: the Rancho Bernardo Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Prediction of rapid bone loss in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Evidence of estrogen receptors in normal human osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

The effect of postmenopausal estrogen therapy on bone density in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After Oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Femoral bone loss progresses with age: a longitudinal study in women over age 65.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Users' Guides to the Medical Literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Menopause and hormone replacement therapy: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Influence of body weight on rates of change in bone density of the spine, hip, and radius in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Rates of change in bone mineral density of the spine, heel, femoral neck and radius in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Prospective trial of oestrogen and calcium in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Increased osteoclast development after estrogen loss: mediation by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Prevention of spinal osteoporosis in oophorectomised women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Bone response to termination of oestrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Cytokines, hematopoiesis, osteoclastogenesis, and estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Do estrogens improve bone mineral density in osteoporotic women over age 65?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Fracture protection provided by long-term estrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Long-term estrogen replacement therapy in postmenopausal women sustains vertebral bone mineral density.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Treatment of spinal osteoporosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Exercise and other factors in the prevention of hip fracture: the Leisure World study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Estrogen therapy arrests bone loss in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Local and systemic factors in the pathogenesis of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Premenopausal and postmenopausal changes in bone mineral density of the proximal femur measured by dual-energy x-ray absorptiometry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Modulation of osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Postmenopausal bone loss at multiple skeletal sites: relationship to estrogen use.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

Cytokine production by peripheral blood cells in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970248-6

7 January 2021

10.1016/S0889-8529(05)70248-6

Identifiers

DOI

1 reference

1 October 2017

1 reference

PubMed ID

9193885